Emily Finnegan

Director - Global Regulatory Affairs, Precision Medicine Digital Health GSK

Seminars

Wednesday 25th March 2026
Exploring the Regulatory Parameters of Digital Pathology in Precision Medicine to Guide Patient Selection & Protocol Design
12:00 pm
  • Utilizing unique AI-powered digital pathology insights to inform patient stratification and selection
  • Integrating digital pathology early into trial design to safeguard clinical success downstream
  • Navigating device and software requirements for use of digital pathology in clinical trials
Emily Finnegan speaker photo